Askaryan radiation
Askaryan radiation is a type of electromagnetic radiation primarily associated with high-energy particle physics. It was first proposed by the Soviet-Armenian physicist Gurgen Askaryan in 1962. This radiation is produced when a high-energy particle interacts with a dense dielectric medium, such as salt, ice or the lunar regolith, and produces a shower of secondary charged particles which collectively exhibit a net negative charge. The radiation is characterized by a coherent radio or microwave Cherenkov radiation emitted by the excess negative charge of the secondary particles in the medium.
Discovery and Theory
Gurgen Askaryan first proposed the existence of this radiation in 1962. He theorized that a high-energy particle interacting with a dense dielectric medium would produce a shower of secondary charged particles. Due to the differences in the cross-sections for the production of positive and negative particles, this shower would exhibit a net negative charge. This charge imbalance would then lead to the emission of coherent Cherenkov radiation in the radio or microwave frequencies.
Detection
The detection of Askaryan radiation is a significant challenge due to the need for a dense dielectric medium and the relatively low intensity of the radiation. However, several experiments have successfully detected this radiation. The ANITA experiment (Antarctic Impulsive Transient Antenna) and the ARA experiment (Askaryan Radio Array) are two notable examples. These experiments use large volumes of Antarctic ice as the dielectric medium and sophisticated radio antennas to detect the radiation.
Applications
The primary application of Askaryan radiation is in the field of neutrino astronomy. Neutrinos are elusive particles that are extremely difficult to detect, but they carry valuable information about cosmic phenomena. The detection of Askaryan radiation provides a unique method for detecting high-energy neutrinos, which can provide insights into cosmic ray sources and other astrophysical phenomena.
See also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD